Editing Psilocybin (section)

==References==
{{Reflist|refs=

<ref name="Agurell1968">{{cite journal | vauthors = Agurell S, Nilsson JL | title = Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives | journal = Acta Chemica Scandinavica | volume = 22 | issue = 4 | pages = 1210–1218 | year = 1968 | pmid = 5750023 | doi = 10.3891/acta.chem.scand.22-1210 | doi-access = free }}</ref>

<ref name="Akers2011">{{Cite journal |vauthors=Akers BP, Ruiz JF, Piper A, Ruck CA |year=2011 |title=A prehistoric mural in Spain depicting neurotropic ''Psilocybe'' mushrooms? |journal=Economic Botany |volume=65 |issue=2 |pages=121–128 |doi=10.1007/s12231-011-9152-5 |s2cid=3955222}}</ref>

<ref name="Albers2004">{{cite journal | vauthors = Albers C, Köhler H, Lehr M, Brinkmann B, Beike J | title = Development of a psilocin immunoassay for serum and blood samples | journal = International Journal of Legal Medicine | volume = 118 | issue = 6 | pages = 326–331 | date = December 2004 | pmid = 15526212 | doi = 10.1007/s00414-004-0469-9 | s2cid = 11249439 }}</ref>

<ref name="Amsterdam2010">{{cite journal | vauthors = van Amsterdam J, Opperhuizen A, Koeter M, van den Brink W | title = Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population | journal = European Addiction Research | volume = 16 | issue = 4 | pages = 202–207 | year = 2010 | pmid = 20606445 | doi = 10.1159/000317249 | s2cid = 207669364 }}</ref>

<ref name="Amsterdam2011">{{cite journal | vauthors = van Amsterdam J, Opperhuizen A, van den Brink W | title = Harm potential of magic mushroom use: a review | journal = Regulatory Toxicology and Pharmacology | volume = 59 | issue = 3 | pages = 423–429 | date = April 2011 | pmid = 21256914 | doi = 10.1016/j.yrtph.2011.01.006 | url = http://dl.dropbox.com/u/85192141/2011-amsterdam.pdf | url-status = dead | archive-url = https://web.archive.org/web/20150109054531/http://dl.dropbox.com/u/85192141/2011-amsterdam.pdf | archive-date = January 9, 2015 }}</ref>

<ref name="Anastos2006">{{cite journal | vauthors = Anastos N, Barnett NW, Pfeffer FM, Lewis SW | title = Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography | journal = Science & Justice | volume = 46 | issue = 2 | pages = 91–96 | year = 2006 | pmid = 17002211 | doi = 10.1016/S1355-0306(06)71579-9 }}</ref>

<ref name="Attema2007">{{cite journal | vauthors = Attema-de Jonge ME, Portier CB, Franssen EJ | title = [Automutilation after consumption of hallucinogenic mushrooms] | language = nl | journal = Nederlands Tijdschrift voor Geneeskunde | volume = 151 | issue = 52 | pages = 2869–2872 | date = December 2007 | pmid = 18257429 | trans-title = Automutilation after consumption of hallucinogenic mushrooms }}</ref>

<ref name="Azmitia2010">{{Cite book |title=Handbook of the Behavioral Neurobiology of Serotonin |vauthors=Azmitia EC |publisher=Academic Press |year=2010 |isbn=978-0-12-374634-4 |veditors=Müller CP, Jacobs BL |location=London, UK |page=7 |chapter=Evolution of serotonin: sunlight to suicide |access-date=February 27, 2016 |chapter-url=https://books.google.com/books?id=aomaKqIE1jUC&pg=PA7 |archive-url=https://web.archive.org/web/20170404000052/https://books.google.com/books?id=aomaKqIE1jUC&pg=PA7 |archive-date=April 4, 2017 |url-status=live}}</ref>

<ref name="Berge1999">{{Cite journal |vauthors=Berge JT |year=1999 |title=Breakdown or breakthrough? A history of European research into drugs and creativity |journal=Journal of Creative Behavior |volume=33 |issue=4 |pages=257–276 |doi=10.1002/j.2162-6057.1999.tb01406.x |issn=0022-0175}}</ref>

<ref name="Bigwood1982">{{cite journal | vauthors = Bigwood J, Beug MW | title = Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer | journal = Journal of Ethnopharmacology | volume = 5 | issue = 3 | pages = 287–291 | date = May 1982 | pmid = 7201054 | doi = 10.1016/0378-8741(82)90014-9 }}</ref>

<ref name="Bone2011">{{Cite book |url=https://books.google.com/books?id=Br3PU2PJhywC&pg=PA258 |title=Mycophilia: Revelations from the Weird World of Mushrooms |vauthors=Bone E |publisher=Rodale |year=2011 |isbn=978-1-60529-407-0 |location=New York, New York |pages=257–258 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170404054348/https://books.google.com/books?id=Br3PU2PJhywC&pg=PA258 |archive-date=April 4, 2017 |url-status=live}}</ref>

<ref name="Bresinsky1989">{{Cite book |url=https://books.google.com/books?id=EIcQGsZ2kksC&pg=PA113 |title=A Colour Atlas of Poisonous Fungi: A Handbook for Pharmacists, Doctors, and Biologists |vauthors=Bresinsky A, Besl H |publisher=Manson Publishing |year=1989 |isbn=978-0-7234-1576-3 |location=London, UK |page=113 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170404052509/https://books.google.com/books?id=EIcQGsZ2kksC&pg=PA113 |archive-date=April 4, 2017 |url-status=live}}</ref>

<ref name="CarhartHarris2010">{{Cite journal | vauthors = Carhart-Harris RL, Nutt DJ |author2-link=David Nutt|year=2010 |title=User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study |journal=Journal of Substance Abuse |volume=15 |issue=4 |pages=283–300 |doi=10.3109/14659890903271624 |s2cid=56427651}}</ref>

<ref name="Carter2005">{{cite journal | vauthors = Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX | title = Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors | journal = Journal of Cognitive Neuroscience | volume = 17 | issue = 10 | pages = 1497–1508 | date = October 2005 | pmid = 16269092 | doi = 10.1162/089892905774597191 | url = http://www.zora.uzh.ch/id/eprint/121457/1/089892905774597191.pdf | url-status = live | access-date = August 16, 2019 | s2cid = 9790150 | archive-url = https://web.archive.org/web/20190816023012/https://www.zora.uzh.ch/id/eprint/121457/1/089892905774597191.pdf | archive-date = August 16, 2019 }}</ref>

<ref name="Chen2008">{{cite journal | vauthors = Chen CY, Storr CL, Anthony JC | title = Early-onset drug use and risk for drug dependence problems | journal = Addictive Behaviors | volume = 34 | issue = 3 | pages = 319–322 | date = March 2009 | pmid = 19022584 | pmc = 2677076 | doi = 10.1016/j.addbeh.2008.10.021 }}</ref>

<ref name="Cole2003">{{Cite book |url=https://archive.org/details/analysisofcontro0000cole/page/132 |title=The Analysis of Controlled Substances |vauthors=Cole MD |publisher=John Wiley and Sons |year=2003 |isbn=978-0-471-49252-8 |location=New York, Chichester |pages=[https://archive.org/details/analysisofcontro0000cole/page/132 132–133]}}</ref>

<ref name=Compasspathways2018>{{Cite web |title=COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression |url=https://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/ |url-status=live |archive-url=https://web.archive.org/web/20181204005741/https://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/ |archive-date=December 4, 2018 |access-date=2018-12-03 |publisher=Compass Pathways}}</ref>

<ref name="Coull2011">{{cite journal | vauthors = Coull JT, Cheng RK, Meck WH | title = Neuroanatomical and neurochemical substrates of timing | journal = Neuropsychopharmacology | volume = 36 | issue = 1 | pages = 3–25 | date = January 2011 | pmid = 20668434 | pmc = 3055517 | doi = 10.1038/npp.2010.113 }}</ref>

<ref name=DeVos2021>{{cite journal | vauthors = de Vos CM, Mason NL, Kuypers KP | title = Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics | journal = Frontiers in Psychiatry | volume = 12 | pages = 724606 | date = 2021 | pmid = 34566723 | pmc = 8461007 | doi = 10.3389/fpsyt.2021.724606 | doi-access = free }}</ref>

<ref name=DosSantos2016>{{cite journal | vauthors = Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE | title = Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years | journal = Therapeutic Advances in Psychopharmacology | volume = 6 | issue = 3 | pages = 193–213 | date = June 2016 | pmid = 27354908 | pmc = 4910400 | doi = 10.1177/2045125316638008 }}</ref>

<ref name="EMCDDA">{{Cite report |url=http://www.emcdda.europa.eu/attachements.cfm/att_31215_EN_TP_Hallucinogenic_mushrooms.pdf |title=Hallucinogenic Mushrooms: An Emerging Trend Case Study |publisher=[[European Monitoring Centre for Drugs and Drug Addiction]] (EMCDDA) |location=Lisbon, Portugal |isbn=92-9168-249-7 |access-date=September 8, 2011 |archive-url=https://web.archive.org/web/20120329044308/http://www.emcdda.europa.eu/attachements.cfm/att_31215_EN_TP_Hallucinogenic_mushroom.pdf |archive-date=March 29, 2012 |vauthors=Hillebrand J, Olszewski D, Sedefov R |year=2006 |url-status=live}}</ref>

<ref name="EMDCCA2011">{{Cite report |url=http://www.emcdda.europa.eu/attachements.cfm/att_143743_EN_EMCDDA_AR2011_EN.pdf |title=Annual report 2011: the state of the drugs problem in Europe |date=November 2011 |publisher=[[Publications Office of the European Union]] |doi=10.2810/44330 |location=Luxembourg |isbn=978-92-9168-470-0 |access-date=December 4, 2011 |archive-url=https://web.archive.org/web/20111203224745/http://www.emcdda.europa.eu/attachements.cfm/att_143743_EN_EMCDDA_AR2011_EN.pdf |archive-date=December 3, 2011 |vauthors=((European Monitoring Centre for Drugs and Drug Addiction)) |url-status=live}}</ref>

<ref name="Fish2006">{{Cite book |title=Drugs and Society: U.S. Public Policy |vauthors=Gable RS |publisher=Rowman & Littlefield |year=2006 |isbn=978-0-7425-4245-7 |veditors=Fish JM |location=Lanham, Maryland |pages=149–162; Table 7.1 "Safety Ratio and Dependence Potential of Psychoactive Drugs" |chapter=Acute toxicity of drugs versus regulatory status |chapter-url=http://web.cgu.edu/faculty/gabler/drug_toxicity.htm |archive-url=https://web.archive.org/web/20120107021458/http://web.cgu.edu/faculty/gabler/drug_toxicity.htm |archive-date=January 7, 2012 |url-status=live}}</ref>

<ref name=Fricke2017>{{cite journal | vauthors = Fricke J, Blei F, Hoffmeister D | title = Enzymatic Synthesis of Psilocybin | journal = Angewandte Chemie | volume = 56 | issue = 40 | pages = 12352–12355 | date = September 2017 | pmid = 28763571 | doi = 10.1002/anie.201705489 }}</ref>

<ref name="Gable2004">{{cite journal | vauthors = Gable RS | title = Comparison of acute lethal toxicity of commonly abused psychoactive substances | journal = Addiction | volume = 99 | issue = 6 | pages = 686–696 | date = June 2004 | pmid = 15139867 | doi = 10.1111/j.1360-0443.2004.00744.x | url = http://web.cgu.edu/faculty/gabler/toxicity%20Addiction%20offprint.pdf | url-status = live | access-date = November 16, 2011 | archive-url = https://web.archive.org/web/20060810063302/http://web.cgu.edu/faculty/gabler/toxicity%20Addiction%20offprint.pdf | archive-date = August 10, 2006 }}</ref>

<ref name="Gartz1992">{{Cite journal |vauthors=Gartz J |year=1992 |title=New aspects of the occurrence, chemistry and cultivation of European hallucinogenic mushrooms |journal=Supplemento Agli Annali dei Musei Civici di Rovereto Sezione Archeologica, Storia e Scienze Naturali |volume=8 |pages=107–124}}</ref>

<ref name="Gartz1996">{{Cite journal |vauthors=Gartz J, Samorini G, Festi F |year=1996 |title=On the presumed French case of fatality caused by ingestion of Liberty Caps |url=http://www.museocivico.rovereto.tn.it/pubblicazioni.jsp?ID_LINK=111251&area=3 |url-status=dead |journal=Eluesis |volume=6 |pages=40–41 |archive-url=https://web.archive.org/web/20120405121903/http://www.museocivico.rovereto.tn.it/pubblicazioni.jsp?ID_LINK=111251&area=3 |archive-date=April 5, 2012}}</ref>

<ref name="Gerault1996">{{Cite journal |vauthors=Gérault A, Picart D |year=1996 |title=Intoxication mortelle à la suite de la consommation volontaire et en groupe de champignons hallucinogènes |trans-title=Fatal poisoning after a group of people voluntarily consumed hallucinogenic mushrooms |journal=Bulletin de la Société Mycologique de France |language=fr |volume=112 |pages=1–14}}</ref>

<ref name="Geyer1998">{{cite journal | vauthors = Geyer MA | title = Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research | journal = Pharmacopsychiatry | volume = 31 | issue = S2 | pages = 73–79 | date = July 1998 | pmid = 9754837 | doi = 10.1055/s-2007-979350 | s2cid = 24647325 }}</ref>

<ref name="Geyer2008">{{cite journal | vauthors = Geyer MA, Vollenweider FX | title = Serotonin research: contributions to understanding psychoses | journal = Trends in Pharmacological Sciences | volume = 29 | issue = 9 | pages = 445–453 | date = September 2008 | pmid = 19086254 | doi = 10.1016/j.tips.2008.06.006 }}</ref>

<ref name=Goel2022>{{cite journal | vauthors = Goel DB, Zilate S | title = Potential Therapeutic Effects of Psilocybin: A Systematic Review | journal = Cureus | volume = 14 | issue = 10 | pages = e30214 | date = October 2022 | pmid = 36381758 | pmc = 9650681 | doi = 10.7759/cureus.30214 | doi-access = free }}</ref>

<ref name="Grieshaber2001">{{cite journal | vauthors = Grieshaber AF, Moore KA, Levine B | title = The detection of psilocin in human urine | journal = Journal of Forensic Sciences | volume = 46 | issue = 3 | pages = 627–630 | date = May 2001 | pmid = 11373000 | doi = 10.1520/JFS15014J }}</ref>

<ref name="Griffiths2006">{{cite journal | vauthors = Griffiths RR, Richards WA, McCann U, Jesse R | title = Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance | journal = Psychopharmacology | volume = 187 | issue = 3 | pages = 268–283 | date = August 2006 | pmid = 16826400 | doi = 10.1007/s00213-006-0457-5 | url = http://www.hopkinsmedicine.org/bin/s/m/GriffithsPsilocybin.pdf | url-status = dead | s2cid = 7845214 | archive-url = https://web.archive.org/web/20111109030153/http://www.hopkinsmedicine.org/bin/s/m/GriffithsPsilocybin.pdf | archive-date = November 9, 2011 }}</ref>

<ref name="Griffiths2008">{{cite journal | vauthors = Griffiths R, Richards W, Johnson M, McCann U, Jesse R | title = Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later | journal = Journal of Psychopharmacology | volume = 22 | issue = 6 | pages = 621–632 | date = August 2008 | pmid = 18593735 | pmc = 3050654 | doi = 10.1177/0269881108094300 | url = http://www.csp.org/psilocybin/Hopkins-CSP-Psilocybin2008.pdf | url-status = dead | access-date = July 3, 2008 | df = mdy-all | archive-url = https://web.archive.org/web/20080722205309/http://www.csp.org/psilocybin/Hopkins-CSP-Psilocybin2008.pdf | archive-date = July 22, 2008 }}</ref><ref name="Griffiths2010">{{Cite journal |vauthors=Griffiths RR, Grob CS |year=2010 |title=Hallucinogens as medicine |url=http://www.csp.org/psilocybin/SciAmHallucinogens201012.pdf |url-status=dead |journal=Scientific American |volume=303 |issue=6 |pages=77–79 |bibcode=2010SciAm.303f..76G |doi=10.1038/scientificamerican1210-76 |archive-url=https://web.archive.org/web/20111003152701/http://csp.org/psilocybin/SciAmHallucinogens201012.pdf |archive-date=October 3, 2011 |access-date=July 25, 2011 |df=mdy-all}}</ref>

<ref name="Gross2000">{{cite journal | vauthors = Gross ST | title = Detecting psychoactive drugs in the developmental stages of mushrooms | journal = Journal of Forensic Sciences | volume = 45 | issue = 3 | pages = 527–537 | date = May 2000 | pmid = 10855955 | doi = 10.1520/JFS14725J | url = http://pdfs.semanticscholar.org/8dab/e1804d761d975ef16e28c2c994476d9122aa.pdf | url-status = dead | s2cid = 38006957 | archive-url = https://web.archive.org/web/20201116074539/http://pdfs.semanticscholar.org/8dab/e1804d761d975ef16e28c2c994476d9122aa.pdf | archive-date = 2020-11-16 }}</ref>

<ref name="Guzman1983">{{Cite book |title=The Genus ''Psilocybe'': A Systematic Revision of the Known Species Including the History, Distribution, and Chemistry of the Hallucinogenic Species |vauthors=Guzmán G |publisher=J.&nbsp;Cramer |year=1983 |isbn=978-3-7682-5474-8 |series=Beihefte Zur Nova Hedwigia. Heft 74 |location=Vaduz, Liechtenstein |pages=361–362}}</ref>

<ref name="Guzman2000">{{Cite journal |vauthors=Guzmán G, Allen JW, Gartz J |year=2000 |title=A worldwide geographical distribution of the neurotropic fungi, an analysis and discussion |url=http://www.museocivico.rovereto.tn.it/UploadDocs/104_art09-Guzman%20&%20C.pdf |url-status=live |journal=Annali del Museo Civico di Rovereto: Sezione Archeologia, Storia, Scienze Naturali |volume=14 |pages=189–280 |archive-url=https://web.archive.org/web/20180205032100/http://www.museocivico.rovereto.tn.it/UploadDocs/104_art09-Guzman%20%26%20C.pdf |archive-date=February 5, 2018 |access-date=October 19, 2021}}</ref>

<ref name="Guzman2005">{{Cite journal |vauthors=Guzmán G |year=2005 |title=Species diversity of the genus ''Psilocybe'' (Basidiomycotina, Agaricales, Strophariaceae) in the world mycobiota, with special attention to hallucinogenic properties |journal=International Journal of Medicinal Mushrooms |volume=7 |issue=1–2 |pages=305–331 |doi=10.1615/intjmedmushr.v7.i12.280}}</ref>

<ref name="Guzman2008">{{Cite journal |vauthors=Guzmán G |year=2008 |title=Hallucinogenic mushrooms in Mexico: an overview |journal=Economic Botany |volume=62 |issue=3 |pages=404–412 |doi=10.1007/s12231-008-9033-8 |bibcode=2008EcBot..62..404G |s2cid=22085876}}</ref>

<ref name="Harrington1999">{{cite journal | vauthors = Harrington DL, Haaland KY | title = Neural underpinnings of temporal processing: a review of focal lesion, pharmacological, and functional imaging research | journal = Reviews in the Neurosciences | volume = 10 | issue = 2 | pages = 91–116 | year = 1999 | pmid = 10658954 | doi = 10.1515/REVNEURO.1999.10.2.91 | s2cid = 25960626 | url = https://escholarship.org/uc/item/0498n8nb }}</ref>

<ref name="Heim1957">{{Cite journal |vauthors=Heim R |year=1957 |title=Notes préliminaires sur les agarics hallucinogènes du Mexique |trans-title=Preliminary notes on the hallucination-producing agarics of Mexico |journal=Revue de Mycologie |language=fr |volume=22 |issue=1 |pages=58–79}}</ref>

<ref name=Hofmann2009>{{Cite book|vauthors=Hofmann A|author-link=Albert Hofmann|title=LSD, my problem child: reflections on sacred drugs, mysticism, and science|publisher=Multidisciplinary Association for Psychedelic Studies|location=Santa Cruz, California|year=2009|isbn=978-0979862229|url=https://archive.org/details/lsdmyproblemchil0000hofm_h2h0/mode/2up}}</ref>

<ref name="Hood1975">{{cite journal | vauthors = Arici M, Altun B, Araz M, Atmaca A, Demir T, Ecder T, Guz G, Gogas Yavuz D, Yildiz A, Yilmaz T | title = The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials | journal = Frontiers in Medicine | volume = 11 | issue = 1 | pages = 1384454 | year = 1975 | pmid = 38947237 | doi = 10.2307/1384454 | s2cid = 147200008 | jstor = 1384454 | pmc = 11214281 }}</ref>

<ref name="HSDB">{{Cite web |title=Psilocybine |url=http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+520-52-5 |url-status=live |archive-url=https://web.archive.org/web/20180813210637/https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+520-52-5 |archive-date=August 13, 2018 |access-date=November 21, 2011 |website=[[Hazardous Substances Data Bank]] |publisher=U.S. National Library of Medicine}}</ref>

<ref name="Hyde1978">{{cite journal | vauthors = Hyde C, Glancy G, Omerod P, Hall D, Taylor GS | title = Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications | journal = The British Journal of Psychiatry | volume = 132 | issue = 6 | pages = 602–604 | date = June 1978 | pmid = 566144 | doi = 10.1192/bjp.132.6.602 | s2cid = 20020560 }}</ref>

<ref name="James1997">{{Cite book |title=The Varieties of Religious Experience |title-link=The Varieties of Religious Experience |vauthors=James W |publisher=Simon & Schuster |year=1997 |isbn=978-0-684-84297-4 |location=New York, New York}}</ref>

<ref name="JHMed: Griffiths Interview">{{Cite news |date=July 11, 2006 |title=Press release: Griffiths psilocybin |url=http://www.hopkinsmedicine.org/Press_releases/2006/GriffithspsilocybinQ |url-status=live |archive-url=https://web.archive.org/web/20110716065016/http://www.hopkinsmedicine.org/Press_releases/2006/GriffithspsilocybinQ |archive-date=July 16, 2011 |access-date=July 12, 2006 |publisher=Johns Hopkins Medicine | vauthors = Simpkins B }}</ref>

<ref name="Johnson2008">{{cite journal | vauthors = Johnson M, Richards W, Griffiths R | title = Human hallucinogen research: guidelines for safety | journal = Journal of Psychopharmacology | volume = 22 | issue = 6 | pages = 603–620 | date = August 2008 | pmid = 18593734 | pmc = 3056407 | doi = 10.1177/0269881108093587 | url = http://csp.org/psilocybin/HopkinsHallucinogenSafety2008.pdf | url-status = dead | access-date = November 20, 2017 | archive-url = https://web.archive.org/web/20171120114306/http://csp.org/psilocybin/HopkinsHallucinogenSafety2008.pdf | archive-date = November 20, 2017 }}</ref>

<ref name="Kamata2003">{{cite journal | vauthors = Kamata T, Nishikawa M, Katagi M, Tsuchihashi H | title = Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples | journal = Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences | volume = 796 | issue = 2 | pages = 421–427 | date = November 2003 | pmid = 14581081 | doi = 10.1016/j.jchromb.2003.08.030 }}</ref>

<ref name="Kamata2010">{{Cite journal |vauthors=Kamata T, Katagi M, Tsuchihashi H |year=2010 |title=Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan |journal=Forensic Toxicology |volume=28 |issue=1 |pages=1–8 |doi=10.1007/s11419-009-0087-9 |s2cid=45118221}}</ref>

<ref name="Keller1999">{{cite journal | vauthors = Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rücker T, Jaspers J, Kisser W | title = Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry | journal = Forensic Science International | volume = 99 | issue = 2 | pages = 93–105 | date = January 1999 | pmid = 10077856 | doi = 10.1016/S0379-0738(98)00168-6 }}</ref>

<ref name="Keim2008">{{Cite magazine |date=July 1, 2008 |title=Psilocybin study hints at rebirth of hallucinogen research |url=https://www.wired.com/wiredscience/2008/07/psilocybin-stud/ |url-status=live |magazine=[[Wired (magazine)|Wired.com]] |archive-url=https://web.archive.org/web/20110803171254/http://www.wired.com/wiredscience/2008/07/psilocybin-stud/ |archive-date=August 3, 2011 |access-date=August 8, 2011 |vauthors=Keim B}}</ref>

<ref name="Kysilka1989">{{cite journal | vauthors = Kysilka R, Wurst M | title = High-performance liquid chromatographic determination of some psychotropic indole derivatives | journal = Journal of Chromatography | volume = 464 | issue = 2 | pages = 434–437 | date = March 1989 | pmid = 2722990 | doi = 10.1016/s0021-9673(00)94264-x }}</ref>

<ref name="Kysilka1990">{{cite journal | vauthors = Kysilka R | title = Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection | journal = Journal of Chromatography | volume = 534 | pages = 287–290 | date = December 1990 | pmid = 2094720 | doi = 10.1016/S0378-4347(00)82176-3 }}</ref>

<ref name="Leary1963">{{cite journal | vauthors = Leary T, Litwin GH, Metzner R | title = Reactions to Psilocybjn Administered in a Supportive Environment | journal = The Journal of Nervous and Mental Disease | volume = 137 | issue = 6 | pages = 561–573 | date = December 1963 | pmid = 14087676 | doi = 10.1097/00005053-196312000-00007 | s2cid = 39777572 }}</ref>

<ref name="Leary1965">{{Cite journal |vauthors=Leary T, Metzner R, Presnell M, Weil G, Schwitzgebel R, Kinne S |year=1965 |title=A new behavior change program using psilocybin |journal=Psychotherapy: Theory, Research & Practice |volume=2 |issue=2 |pages=61–72 |doi=10.1037/h0088612}}</ref>

<ref name="Lee1985">{{cite journal | vauthors = Lee RE | title = A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms | journal = Journal of Forensic Sciences | volume = 30 | issue = 3 | pages = 931–941 | date = July 1985 | pmid = 4040953 | doi = 10.1520/JFS11028J }}</ref>

<ref name="Levine2003">{{Cite book |title=Principles of Forensic Toxicology |vauthors=Jenkins AJ |publisher=American Association for Clinical Chemistry Press |year=2003 |isbn=978-1-890883-87-4 |veditors=Levine B |edition=2nd |location=Washington, D.C. |page=281 |chapter=Hallucinogens |access-date=February 27, 2016 |chapter-url=https://books.google.com/books?id=k7BInEQ-iqgC&pg=PA281 |archive-url=https://web.archive.org/web/20170403111310/https://books.google.com/books?id=k7BInEQ-iqgC&pg=PA281 |archive-date=April 3, 2017 |url-status=live}}</ref>

<ref name="Lindenblatt1998">{{cite journal | vauthors = Lindenblatt H, Krämer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA | title = Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction | journal = Journal of Chromatography. B, Biomedical Sciences and Applications | volume = 709 | issue = 2 | pages = 255–263 | date = May 1998 | pmid = 9657222 | doi = 10.1016/S0378-4347(98)00067-X }}</ref>

<ref name=Lurie2009>{{Cite journal |vauthors=Lurie I, Li L |year=2009 |title=Use of high-temperature liquid chromatography with sub-2 μm particle C<sub>18</sub> columns for the analysis of seized drugs |url=https://zenodo.org/record/1234491 |url-status=live |journal=Journal of Liquid Chromatography & Related Technologies |volume=32 |issue=17–20 |pages=2615–2626 |doi=10.1080/10826070903245516 |archive-url=https://web.archive.org/web/20210503052027/https://zenodo.org/record/1234491 |archive-date=May 3, 2021 |access-date=August 24, 2020 |s2cid=96753191}}</ref>

<ref name="Mack1983">{{cite journal | vauthors = Mack RB | title = Phenomenally phunny phungi--psilocybin toxicity | journal = North Carolina Medical Journal | volume = 44 | issue = 10 | pages = 639–640 | date = October 1983 | pmid = 6580536 }}</ref>

<ref name=Marley2010>{{Cite book|vauthors=Marley G|title=Chanterelle Dreams, Amanita Nightmares: The Love, Lore, and Mystique of Mushrooms|publisher=Chelsea Green Publishing|location=White River Junction, Vermont|year=2010|isbn=978-1603582148}}</ref>

<ref name="Matsushima2009">{{Cite journal |vauthors=Matsushima Y, Eguchi F, Kikukawa T, Matsuda T |year=2009 |title=Historical overview of psychoactive mushrooms |journal=Inflammation and Regeneration |volume=29 |issue=1 |pages=47–58 |doi=10.2492/inflammregen.29.47 |doi-access=free}}</ref>

<ref name="McKenna1992">{{Cite book |title=Food of the Gods: The Search for the Original Tree of Knowledge. A Radical History of Plants, Drugs, and Human Evolution |vauthors=McKenna T |publisher=Bantam Books |year=1993 |isbn=978-0-553-37130-7 |location=New York, New York}}</ref>

<ref name="Merck13th">{{Cite book |url=https://archive.org/details/merckindexency00onei/page/1419 |title=The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals |publisher=Merck |year=2001 |isbn=978-0-911910-13-1 |veditors=O'Neil MJ, Smith A, Heckelman PE, Obenchain JR, Gallipeau JR, D'Arecca MA |edition=13th |location=Whitehouse Station, New Jersey |page=[https://archive.org/details/merckindexency00onei/page/1419 1419]}}</ref>

<ref name="Metzner1998">{{cite journal | vauthors = Metzner R | title = Hallucinogenic drugs and plants in psychotherapy and shamanism | journal = Journal of Psychoactive Drugs | volume = 30 | issue = 4 | pages = 333–341 | year = 1998 | pmid = 9924839 | doi = 10.1080/02791072.1998.10399709 | url = http://cdn.preterhuman.net/texts/religion.occult.new_age/occult_library/Metzner_R-Hallucinogenic_Plants.pdf | url-status = live | access-date = October 26, 2017 | citeseerx = 10.1.1.509.4769 | archive-url = https://web.archive.org/web/20170921233753/http://cdn.preterhuman.net/texts/religion.occult.new_age/occult_library/Metzner_R-Hallucinogenic_Plants.pdf | archive-date = September 21, 2017 }}</ref>

<ref name="Miller2008">{{Cite web |date=July 1, 2008 |title=A very memorable trip |url=https://www.science.org/content/article/very-memorable-trip |url-status=live |archive-url=https://web.archive.org/web/20180813175432/https://www.sciencemag.org/news/2008/07/very-memorable-trip |archive-date=August 13, 2018 |access-date=August 8, 2011 |publisher=sciencemag.org |vauthors=Miller G}}</ref>

<ref name=Milne2020>{{cite journal | vauthors = Milne N, Thomsen P, Mølgaard Knudsen N, Rubaszka P, Kristensen M, Borodina I | title = Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives | journal = Metabolic Engineering | volume = 60 | issue =  | pages = 25–36 | date = July 2020 | pmid = 32224264 | pmc = 7232020 | doi = 10.1016/j.ymben.2019.12.007 }}</ref>

<ref name="Myers1998">{{Cite journal |vauthors=Myers LS, Watkins SS, Carter TJ |year=1998 |title=Flashbacks in theory and practice |url=http://www.heffter.org/docs/hrireview/01/chapter7.pdf |url-status=live |journal=The Heffter Review of Psychedelic Research |volume=1 |pages=51–57 |archive-url=https://web.archive.org/web/20110927212935/http://www.heffter.org/docs/hrireview/01/chapter7.pdf |archive-date=September 27, 2011 |access-date=August 14, 2011}}</ref>

<ref name="Nicholas2006">{{Cite book |url=https://books.google.com/books?id=HJJmJYCl3HsC&pg=PA164 |title=Psilocybin Mushroom Handbook: Easy Indoor and Outdoor Cultivation |vauthors=Nicholas LG, Ogame K |publisher=Quick American Archives |year=2006 |isbn=978-0-932551-71-9 |location=Oakland, California |page=164 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170404053525/https://books.google.com/books?id=HJJmJYCl3HsC&pg=PA164 |archive-date=April 4, 2017 |url-status=live}}</ref>

<!--ref name=Nutt2007>{{Cite journal |vauthors=Nutt DJ, King LA, Saulsbury W, Blakemore C |year=2007 |title=Development of a rational scale to assess the harm of drugs of potential misuse |journal=Lancet |volume=369 |issue=9566 |pages=1047–1053 |doi=10.1016/S0140-6736(07)60464-4 |pmid=17382831}}</ref-->

<ref name="Nutt2010">{{cite journal | vauthors = Nutt DJ, King LA, Phillips LD | title = Drug harms in the UK: a multicriteria decision analysis | journal = Lancet | volume = 376 | issue = 9752 | pages = 1558–1565 | date = November 2010 | pmid = 21036393 | doi = 10.1016/S0140-6736(10)61462-6 | s2cid = 5667719 | citeseerx = 10.1.1.690.1283 }}</ref>

<ref name="Oeric1991">{{Cite book |title=Psilocybin: Magic Mushroom Grower's Guide |vauthors=Oeric OT, Os ON |publisher=Quick American Archives |year=1991 |isbn=978-0-932551-06-1 |edition=2nd |location=San Francisco, California}}</ref>

<ref name="Ohenoja1987">{{cite journal | vauthors = Ohenoja E, Jokiranta J, Mäkinen T, Kaikkonen A, Airaksinen MM | title = The occurrence of psilocybin and psilocin in Finnish fungi | journal = Journal of Natural Products | volume = 50 | issue = 4 | pages = 741–744 | year = 1987 | pmid = 3430170 | doi = 10.1021/np50052a030 | bibcode = 1987JNAtP..50..741O }}</ref>

<ref name=Olson2021>{{cite journal | vauthors = Olson DE | title = Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics | journal = Journal of Experimental Neuroscience | volume = 12 | pages = 1179069518800508 | date = 2018-09-19 | pmid = 30262987 | pmc = 6149016 | doi = 10.1177/1179069518800508 }}</ref>

<ref name="Pagliaro2012">{{Cite book |url=https://books.google.com/books?id=Ox0U5nIZRQ8C&pg=PT257 |title=Handbook of Child and Adolescent Drug and Substance Abuse: Pharmacological, Developmental, and Clinical Considerations |vauthors=Pagliaro LA, Pagliaro AM |publisher=John Wiley & Sons |year=2012 |isbn=978-0-470-63906-1 |edition=2nd |location=Hoboken, New Jersey |page=199 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170403111656/https://books.google.com/books?id=Ox0U5nIZRQ8C&pg=PT257 |archive-date=April 3, 2017 |url-status=live}}</ref>

<ref name="Pahnke1966">{{Cite journal |vauthors=Pahnke WN |year=1966 |title=Drugs and mysticism |journal=International Journal of Parapsychology |volume=8 |issue=2 |pages=295–315}}</ref>

<ref name="Pahnke1969">{{cite journal | vauthors = Pahnke WN, Richards WA | title = Implications of LSD and experimental mysticism | journal = Journal of Religion and Health | volume = 5 | issue = 3 | pages = 175–208 | date = July 1966 | pmid = 24424798 | doi = 10.1007/BF01532646 | s2cid = 18464414 }}</ref>

<ref name="Passie2002">{{cite journal | vauthors = Passie T, Seifert J, Schneider U, Emrich HM | title = The pharmacology of psilocybin | journal = Addiction Biology | volume = 7 | issue = 4 | pages = 357–364 | date = October 2002 | pmid = 14578010 | doi = 10.1080/1355621021000005937 | url = https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=981b848a2785bc0c9b5a9afa1162c0c43b4d96c9 | quote = An interesting fact may be the much shorter half-life (mean 74.1 ± 19.6 minutes i.v. compared to 163 ± 64 minutes p.o.) and duration of action (subjective effects lasting only 15–30 minutes) when psilocybin is given intravenously, as performed in a recent double-blind placebo controlled trial.29 | s2cid = 12656091 }}</ref>

<ref name="Passie2008">{{cite journal | vauthors = Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A | title = The pharmacology of lysergic acid diethylamide: a review | journal = CNS Neuroscience & Therapeutics | volume = 14 | issue = 4 | pages = 295–314 | year = 2008 | pmid = 19040555 | pmc = 6494066 | doi = 10.1111/j.1755-5949.2008.00059.x }}</ref>

<ref name="Peden1982">{{cite journal | vauthors = Peden NR, Pringle SD, Crooks J | title = The problem of psilocybin mushroom abuse | journal = Human Toxicology | volume = 1 | issue = 4 | pages = 417–424 | date = October 1982 | pmid = 7173927 | doi = 10.1177/096032718200100408 | s2cid = 7453965 }}</ref>

<ref name="Pedersen1997">{{cite journal | vauthors = Pedersen-Bjergaard S, Sannes E, Rasmussen KE, Tønnesen F | title = Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis | journal = Journal of Chromatography. B, Biomedical Sciences and Applications | volume = 694 | issue = 2 | pages = 375–381 | date = July 1997 | pmid = 9252052 | doi = 10.1016/S0378-4347(97)00127-8 }}</ref>

<ref name="Pubchem">{{Cite web |title=Psilocybine – Compound Summary |url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=10624 |url-status=live |archive-url=https://web.archive.org/web/20120925014943/http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=10624 |archive-date=September 25, 2012 |access-date=December 4, 2011 |publisher=[[PubChem]]. [[National Library of Medicine]]}}</ref>

<ref name="Quentin1960">{{Cite thesis |title=La Psilocybine en Psychiatrie Clinique et Experimentale |degree=PhD |publisher=Paris University Medical Dissertation |language=fr |trans-title=Psilocybin in Clinical and Experimental Psychiatry |vauthors=Quentin AM |year=1960 |location=Paris, France}}</ref>

<ref name="Reinert2020">{{cite journal | vauthors = Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL | title = Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review | journal = Expert Review of Clinical Pharmacology | volume = 13 | issue = 8 | pages = 847–856 | date = August 2020 | pmid = 32648791 | doi = 10.1080/17512433.2020.1794811 | type = Review | s2cid = 220472473 }}</ref>

<ref name=Reynolds2018>{{cite journal | vauthors = Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC | title = Horizontal gene cluster transfer increased hallucinogenic mushroom diversity | journal = Evolution Letters | volume = 2 | issue = 2 | pages = 88–101 | date = April 2018 | pmid = 30283667 | pmc = 6121855 | doi = 10.1002/evl3.42 }}</ref>

<ref name="Richards2008">{{Cite journal |vauthors=Richards WA |year=2008 |title=The phenomenology and potential religious import of states of consciousness facilitated by psilocybin |journal=Archive for the Psychology of Religion |volume=30 |issue=1 |pages=189–199 |doi=10.1163/157361208X317196 |s2cid=144969540}}</ref>

<ref name="RodriguezCruz2005">{{Cite journal |vauthors=Rodriguez-Cruz SE |year=2005 |title=Analysis and characterization of psilocybin and psilocin using liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) with collision-induced-dissociation (CID) and source-induced dissociation (SID) |url=https://www.justice.gov/dea/programs/forensicsci/microgram/journal_v3_num34/journal_v3_num34_pg8.html |url-status=dead |journal=Microgram Journal |volume=3 |issue=3–4 |pages=175–82 |archive-url=https://web.archive.org/web/20110429075012/http://www.justice.gov/dea/programs/forensicsci/microgram/journal_v3_num34/journal_v3_num34_pg8.html |archive-date=April 29, 2011}}</ref>

<ref name=Ross2016>{{cite journal | vauthors = Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL | title = Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial | journal = Journal of Psychopharmacology | volume = 30 | issue = 12 | pages = 1165–1180 | date = December 2016 | pmid = 27909164 | pmc = 5367551 | doi = 10.1177/0269881116675512 }}</ref>

<ref name="Saito2004">{{Cite journal |vauthors=Saito K, Toyo'oka T, Fukushima T, Kato M, Shirota O, Goda Y |year=2004 |title=Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry |journal=Analytica Chimica Acta |volume=527 |issue=2 |pages=149–156 |doi=10.1016/j.aca.2004.08.071|bibcode=2004AcAC..527..149S }}</ref>

<ref name="Saupe1981">{{Cite journal |vauthors=Saupe SG |year=1981 |title=Occurrence of psilocybin/psilocin in ''Pluteus salicinus'' (Plutaceae) |url=http://www.cybertruffle.org.uk/cyberliber/59350/0073/004/0781.htm |url-status=live |journal=Mycologia |volume=73 |issue=4 |pages=871–874 |doi=10.2307/3759505 |jstor=3759505 |archive-url=https://web.archive.org/web/20170310224135/http://www.cybertruffle.org.uk/cyberliber/59350/0073/004/0781.htm |archive-date=March 10, 2017 |access-date=August 29, 2011}}</ref>

<ref name="Schaefer2001">{{Cite book |url=https://books.google.com/books?id=CE569saGK70C&pg=PA222 |title=Drugs During Pregnancy and Lactation: Handbook of Prescription Drugs and Comparative Risk Assessment |vauthors=Schaefer C |publisher=Elsevier |year=2001 |isbn=978-0-444-50763-1 |location=Amsterdam, the Netherlands |page=222 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170403152804/https://books.google.com/books?id=CE569saGK70C&pg=PA222 |archive-date=April 3, 2017 |url-status=live}}</ref>

<ref name=Serreau2023>{{cite journal | vauthors = Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S | title = A Review of Synthetic Access to Therapeutic Compounds Extracted from ''Psilocybe'' | journal = Pharmaceuticals | volume = 16 | issue = 1 | pages = 40 | date = December 2022 | pmid = 36678537 | pmc = 9867295 | doi = 10.3390/ph16010040 | doi-access = free }}</ref>

<ref name="Simeon2011">{{cite journal | vauthors = Simeon D | title = Depersonalisation disorder: a contemporary overview | journal = CNS Drugs | volume = 18 | issue = 6 | pages = 343–354 | year = 2004 | pmid = 15089102 | doi = 10.2165/00023210-200418060-00002 | s2cid = 18506672 }}</ref>

<ref name="Smith2000">{{Cite book |url=https://archive.org/details/cleansingdoorsof00hust/page/101 |title=Cleansing the Doors of Perception: The Religious Significance of Entheogenic Plants and Chemicals |vauthors=Smith H |publisher=Jeremy P. Tarcher/Putnam |year=2000 |isbn=978-1-58542-034-6 |location=New York, New York |page=[https://archive.org/details/cleansingdoorsof00hust/page/101 101]}}</ref>

<ref name=Staines2019>{{Cite web | vauthors = Staines R |date=2 December 2019 |title=FDA tags psilocybin drug as clinical depression Breakthrough Therapy |url=https://pharmaphorum.com/news/fda-tags-psilocybin-drug-as-clinical-depression-breakthrough-therapy/ |url-status=live |archive-url=https://web.archive.org/web/20210907170203/https://pharmaphorum.com/news/fda-tags-psilocybin-drug-as-clinical-depression-breakthrough-therapy/ |archive-date=September 7, 2021 |access-date=7 September 2021 |publisher=Pharmaphorum}}</ref>

<ref name="Sticht2000">{{cite journal | vauthors = Sticht G, Käferstein H | title = Detection of psilocin in body fluids | journal = Forensic Science International | volume = 113 | issue = 1–3 | pages = 403–407 | date = September 2000 | pmid = 10978655 | doi = 10.1016/S0379-0738(00)00213-9 }}</ref>

<ref name="Strassman2008">{{Cite book |url=https://books.google.com/books?id=0P3_kfFtgicC&pg=PT164 |title=Inner Paths to Outer Space: Journeys to Alien Worlds through Psychedelics and Other Spiritual Technologies |vauthors=Strassman R, Wojtowicz S, Luna LE, Frecska E |publisher=Park Street Press |year=2008 |isbn=978-1-59477-224-5 |location=Rochester, Vermont |page=147 |access-date=February 27, 2016 |archive-url=https://web.archive.org/web/20170404064811/https://books.google.com/books?id=0P3_kfFtgicC&pg=PT164 |archive-date=April 4, 2017 |url-status=live}}</ref>

<ref name="Studerus2011">{{cite journal | vauthors = Studerus E, Kometer M, Hasler F, Vollenweider FX | title = Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies | journal = Journal of Psychopharmacology | volume = 25 | issue = 11 | pages = 1434–1452 | date = November 2011 | pmid = 20855349 | doi = 10.1177/0269881110382466 | s2cid = 22923427 }}</ref>

<ref name="urlEMCDDA">{{Cite web |date=September 19, 2011 |title=Drug profiles: Hallucinogenic mushrooms |url=http://www.emcdda.europa.eu/publications/drug-profiles/mushrooms |url-status=live |archive-url=https://web.archive.org/web/20111127192429/http://www.emcdda.europa.eu/publications/drug-profiles/mushrooms |archive-date=November 27, 2011 |access-date=December 4, 2011 |publisher=European Monitoring Centre for Drugs and Drug Addiction}}</ref>

<ref name="urlMedical News">{{Cite web |date=July 12, 2006 |title=Medical News: Psilocybin Viewed as Therapy or Research Tool |url=http://www.medpagetoday.com/Psychiatry/GeneralPsychiatry/tb/3721 |url-status=live |archive-url=https://web.archive.org/web/20081005205255/http://www.medpagetoday.com/Psychiatry/GeneralPsychiatry/tb/3721 |archive-date=October 5, 2008 |access-date=February 12, 2011 |website=Medpagetoday.com |vauthors=Smith M}}</ref>

<ref name="Vollenweider1998">{{cite journal | vauthors = Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D | title = Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action | journal = NeuroReport | volume = 9 | issue = 17 | pages = 3897–3902 | date = December 1998 | pmid = 9875725 | doi = 10.1097/00001756-199812010-00024 | url = http://pdfs.semanticscholar.org/b67b/b9f54c0e79bc73c8b205304a2f0d29eeb2a9.pdf | url-status = dead | s2cid = 37706068 | archive-url = https://web.archive.org/web/20190303134817/http://pdfs.semanticscholar.org/b67b/b9f54c0e79bc73c8b205304a2f0d29eeb2a9.pdf | archive-date = 2019-03-03 }}</ref>

<ref name="Vollenweider2001">{{cite journal | vauthors = Vollenweider FX, Geyer MA | title = A systems model of altered consciousness: integrating natural and drug-induced psychoses | journal = Brain Research Bulletin | volume = 56 | issue = 5 | pages = 495–507 | date = November 2001 | pmid = 11750795 | doi = 10.1016/S0361-9230(01)00646-3 | s2cid = 230298 }}</ref>

<ref name="Wackermann2008">{{cite journal | vauthors = Wackermann J, Wittmann M, Hasler F, Vollenweider FX | title = Effects of varied doses of psilocybin on time interval reproduction in human subjects | journal = Neuroscience Letters | volume = 435 | issue = 1 | pages = 51–55 | date = April 2008 | pmid = 18325673 | doi = 10.1016/j.neulet.2008.02.006 | s2cid = 22789140 }}</ref>

<ref name="Wark2009">{{cite journal | vauthors = Wark C, Galliher JF | title = Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin | journal = The International Journal on Drug Policy | volume = 21 | issue = 3 | pages = 234–239 | date = May 2010 | pmid = 19744846 | doi = 10.1016/j.drugpo.2009.08.004 }}</ref>

<ref name="Wasson1957">{{Cite magazine |date=May 13, 1957 |title=Seeking the magic mushroom |url=https://books.google.com/books?id=Jj8EAAAAMBAJ&pg=PA101 |url-status=live |magazine=Life |pages=101–120 |issn=0024-3019 |archive-url=https://web.archive.org/web/20170403231812/https://books.google.com/books?id=Jj8EAAAAMBAJ&pg=PA101 |archive-date=April 3, 2017 |access-date=February 27, 2016 |vauthors=Wasson RG}}</ref>

<ref name=Wieckiewicz2021>{{cite journal | vauthors = Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R | title = Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review | journal = Pharmaceuticals | volume = 14 | issue = 8 | page = 793 | date = August 2021 | pmid = 34451890 | pmc = 8399008 | doi = 10.3390/ph14080793 | doi-access = free }}</ref>

<ref name="Winkelman2007">{{Cite book |title=Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments |vauthors=Winkelman MJ |publisher=Praeger |year=2007 |isbn=978-0-275-99024-4 |veditors=Winkelman MJ, Roberts TB |volume=1 |location=Westport, Connecticut |pages=[https://archive.org/details/psychedelicmedic0000unse/page/1 1–19] |chapter=Therapeutic bases of psychedelic medicines: psychointegrative effects |chapter-url=https://archive.org/details/psychedelicmedic0000unse/page/1}}</ref>

<ref name="Wittmann2007">{{cite journal | vauthors = Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX | title = Effects of psilocybin on time perception and temporal control of behaviour in humans | journal = Journal of Psychopharmacology | volume = 21 | issue = 1 | pages = 50–64 | date = January 2007 | pmid = 16714323 | doi = 10.1177/0269881106065859 | s2cid = 3165579 }}</ref>

<ref name=Wong2022>{{cite journal | vauthors = Wong G, Lim LR, Tan YQ, Go MK, Bell DJ, Freemont PS, Yew WS | title = Reconstituting the complete biosynthesis of D-lysergic acid in yeast | journal = Nature Communications | volume = 13 | issue = 1 | pages = 712 | date = February 2022 | pmid = 35132076 | pmc = 8821704 | doi = 10.1038/s41467-022-28386-6 | bibcode = 2022NatCo..13..712W }}</ref>

<ref name="Wurst1984">{{Cite journal |vauthors=Wurst M, Semerdžieva M, Vokoun J |year=1984 |title=Analysis of psychotropic compounds in fungi of the genus ''Psilocybe'' by reversed-phase high performance liquid chromatography |journal=Journal of Chromatography A |volume=286 |pages=229–235 |doi=10.1016/S0021-9673(01)99190-3}}</ref>

<ref name="Wurst1992">{{Cite journal |vauthors=Wurst M, Kysilka R, Koza T |year=1992 |title=Analysis and isolation of indole alkaloids of fungi by high-performance liquid chromatography |journal=Journal of Chromatography |volume=593 |issue=1–2 |pages=201–208 |doi=10.1016/0021-9673(92)80287-5}}</ref>

<ref name="Wurst2002">{{cite journal | vauthors = Wurst M, Kysilka R, Flieger M | title = Psychoactive tryptamines from basidiomycetes | journal = Folia Microbiologica | volume = 47 | issue = 1 | pages = 3–27 | year = 2002 | pmid = 11980266 | doi = 10.1007/BF02818560 | s2cid = 31056807 }}</ref>

}}